Stockscreener 앱 받기
2.20
5.98%
-0.14
시간 외 거래:
2.21
0.010
+0.45%
전일 마감가:
$2.34
열려 있는:
$2.29
하루 거래량:
278.84K
Relative Volume:
0.74
시가총액:
$50.21M
수익:
-
순이익/손실:
$-16.51M
주가수익비율:
-1.6263
EPS:
-1.3528
순현금흐름:
$-15.68M
1주 성능:
-8.71%
1개월 성능:
-13.39%
6개월 성능:
-50.11%
1년 성능:
+0.00%
1일 변동 폭
$2.15
$2.35
1주일 범위
$2.15
$2.5999
52주 변동 폭
$1.7901
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
명칭
Medicus Pharma Ltd
전화
610-540-7515
주소
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
MDCX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
2.20 | 50.21M | 0 | -16.51M | -15.68M | -1.3528 |
|
LLY
Lilly Eli Co
|
906.86 | 802.41B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
186.86 | 448.76B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
215.89 | 374.44B | 59.64B | 2.37B | 18.24B | 1.331 |
|
NVS
Novartis Ag Adr
|
125.01 | 237.66B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
83.86 | 206.04B | 63.99B | 19.05B | 14.72B | 7.5596 |
Medicus Pharma Ltd 주식(MDCX)의 최신 뉴스
Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject - Treasure Coast News
What risks investors should watch in Medicus Pharma Ltd. Equity Warrant stockWeekly Profit Report & Smart Money Movement Tracker - newser.com
How strong is Medicus Pharma Ltd. Equity Warrant stock revenue growth2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Applying Elliott Wave Theory to Medicus Pharma Ltd. Equity WarrantJuly 2025 Drop Watch & Comprehensive Market Scan Insights - newser.com
Will Medicus Pharma Ltd. stock benefit from commodity pricesLong Setup & Free Growth Oriented Trading Recommendations - newser.com
What MACD and RSI say about Medicus Pharma Ltd.Weekly Trend Summary & AI Forecasted Stock Moves - newser.com
How Medicus Pharma Ltd. (N460) stock behaves under inflation pressureTrend Reversal & Free Reliable Trade Execution Plans - newser.com
Will Medicus Pharma Ltd. Equity Warrant stock see insider buyingJuly 2025 Fed Impact & Consistent Profit Trading Strategies - newser.com
Medicus Pharma Ltd. Equity Warrant stock momentum explainedJuly 2025 Rallies & Comprehensive Market Scan Reports - newser.com
Technical analysis overview for Medicus Pharma Ltd. Equity Warrant stockProfit Target & Stepwise Entry/Exit Trade Alerts - newser.com
Technical signs of recovery in Medicus Pharma Ltd.Product Launch & Safe Entry Zone Tips - newser.com
Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - The News Journal
How Medicus Pharma Ltd. (N460) stock reacts to monetary easingIndex Update & AI Forecasted Entry and Exit Points - newser.com
How resilient is Medicus Pharma Ltd. Equity Warrant stock in market downturnsMarket Sentiment Review & Free High Return Stock Watch Alerts - newser.com
How hedge fund analytics apply to Medicus Pharma Ltd. stockJuly 2025 Summary & Verified Technical Signals - newser.com
Should you wait for a breakout in Medicus Pharma Ltd.Quarterly Earnings Report & Long Hold Capital Preservation Plans - newser.com
Is Medicus Pharma Ltd. Equity Warrant meeting your algorithmic filter criteria2025 Institutional Moves & Community Verified Swing Trade Signals - newser.com
Is Medicus Pharma Ltd. Equity Warrant stock supported by innovation pipelineVolume Spike & Weekly Watchlist for Consistent Profits - newser.com
How Medicus Pharma Ltd. Equity Warrant stock benefits from global expansionMarket Performance Summary & Weekly Breakout Stock Alerts - newser.com
What drives Medicus Pharma Ltd Equity Warrant stock priceMarket Entry Points & Affordable Trading Techniques - earlytimes.in
Is Medicus Pharma Ltd. (N460) stock a fit for income portfoliosJuly 2025 Levels & High Accuracy Buy Signal Tips - newser.com
Why Medicus Pharma Ltd. (N460) stock could be top winnerTrade Volume Report & Weekly Setup with ROI Potential - newser.com
Medicus Pharma Ltd. To Present at Brookline Capital Markets - Courier & Press
Chart based exit strategy for Medicus Pharma Ltd. Equity WarrantDip Buying & Advanced Swing Trade Entry Alerts - newser.com
Medicus Pharma eyes compassionate use approval of Skinject for Gorlin SyndromeICYMI - Proactive financial news
Why Medicus Pharma Ltd. Equity Warrant stock is favored by pension funds2025 Momentum Check & AI Enhanced Execution Alerts - newser.com
Is Medicus Pharma Ltd. Equity Warrant stock a safe buy before earningsJuly 2025 Selloffs & Risk Managed Investment Signals - newser.com
Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC) - The Holland Sentinel
Real time breakdown of Medicus Pharma Ltd. stock performanceDividend Hike & AI Enhanced Trade Execution Alerts - newser.com
Medicus Pharma Ltd. stock trendline breakdown2025 Key Highlights & Community Verified Swing Trade Signals - newser.com
Medicus Pharma Ltd (MDCX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.88%
0.78%
자본화:
|
볼륨(24시간):